Accelerating the discovery and development of novel small molecule therapeutics inspired by naturally occurring compounds and traditional remedies.

powered by nature.
powered by nature.
powered by nature.
powered by nature.
powered by nature.
powered by nature.
Our Core

Nature-derived drug discovery.

Pangea harnesses the tools of modern drug discovery to develop nature-inspired therapeutics for unmet patient needs. We have the ability to execute and deliver, with a scalable and diversified platform operating model and an experienced team.

explained in short

Pangea Botanica is a biotechnology company advancing the field of drug discovery and development through the therapeutic potential of nature. We have incubated four development programs, each focusing on different nature-inspired compounds and producing high-potential leads.

Facts and figures

Pushing for a better tomorrow.


Pre-clinical lead compounds

We have 5 preclinical lead compounds excluding discovery pipeline across 4 programs. Our programs are developing drugs to target inflammation, autoimmune, psychiatric, neurodegenerative and neurological indications. Further growth of the platform will be supported by our proprietary PangeAI discovery engine.

> 65%

Drugs discovered from natural sources

There is meaningful potential to develop drugs inspired by nature given its co-evolution with human biology, vast chemical diversity, polypharmacology (multiple drug targets) and prior human use, an indicator of efficacy and safety.

< 1%

Mapped and explored small molecules from nature

Nature is one of the richest untapped sources of possible therapeutic compounds. Only less than 1% of nature's small molecules have been mapped and explored. Pangea remains conscious of the remaining 99% which could be explored at scale.


Programs launched

Pangea Botanica assembles uncorrelated programs across therapeutic areas, increasing the likelihood of successful commercialization. To date, Pangea comprises four development programs, Kanna Health, the OTT program, KT program and AH program.

The evolving Pangea ecosystem

Patients around the world have high unmet medical needs, with 52% of the population suffering from at least one chronic disease, and 95% of rare diseases having no approved treatment. Our four development programs research and trial different bioactive compounds across a range of indications.

Kanna Health
OTT program
KT program
AH program
Subscribe to our newsletter

We send our newsletter regularly, sharing news and trends around Pangea Botanica, its ecosystem of operating companies and our research space.

Thank you! We have sent you an email to confirm your subscription!
Oops! Something went wrong while submitting the form.
Inspired by nature.
Powered by technology.
Preserving knowledge.
Empowered by nature.
Empowered by nature.
Empowered by nature.
Empowered by nature.
Empowered by nature.